Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: A phase 1 safety and pharmacokinetics study

Giovanni Martinelli, Vivian G. Oehler, Cristina Papayannidis, Rachel Courtney, M. Naveed Shaik, Xiaoxi Zhang, Ashleigh O'Connell, Karen R. McLachlan, Xianxian Zheng, Jerald Radich, Michele Baccarani, Hagop M. Kantarjian, Wendy J. Levin, Jorge E. Cortes, Catriona Jamieson

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: A phase 1 safety and pharmacokinetics study'. Together they form a unique fingerprint.

Medicine & Life Sciences